过去一年中添加的文章，按日期排序
Molecular Aspects of Inflammation and Lipid Metabolism in Health and Disease: The Role of the Mitochondria
VN Sukhorukov, AN Orekhov - International Journal of Molecular …, 2024 - mdpi.com
16 天前 - … new therapeutic targets for patients with metabolic disorders, cardiovascular diseases,
and chronic inflammatory diseases… The pro-inflammatory cytokine IL-6 increases hepatic …
and chronic inflammatory diseases… The pro-inflammatory cytokine IL-6 increases hepatic …
Dual-mode action of scalable, high-quality engineered stem cell-derived SIRP alpha extracellular vesicles for treating acute liver failure
S Kim, YK Kim, S Kim, YS Choi, I Lee, H Joo, J Kim… - bioRxiv, 2024 - biorxiv.org
26 天前 - … CD47 and SIRP as promising therapeutic targets for ALF. We … liver damage in
ALF models. (A) Representative histological images of H&E, TUNEL, and CD47 staining in liver …
ALF models. (A) Representative histological images of H&E, TUNEL, and CD47 staining in liver …
Role of metabolic dysfunction and inflammation along the liver–brain axis in animal models with obesityinduced neurodegeneration
E Asimakidou, EN Saipuljumri, CH Lo… - Neural Regeneration … - journals.lww.com
31 天前 - … like type 2 diabetes and non-alcoholic fatty liver disease … for identifying novel
therapeutic targets and improving … Inflammatory cytokines such as interleukins IL-1α, IL-6, and …
therapeutic targets and improving … Inflammatory cytokines such as interleukins IL-1α, IL-6, and …
OPEN ACCESS EDITED BY
RJ Brummer, H Li, A Alisi, CJ Beltrán… - … Health and Disease, 2024 - books.google.com
54 天前 - … -alcoholic fatty liver disease (NAFLD) is a liver disorder … possible therapeutic targets
directed at controlling hepatic … the release of inflammatory cytokines by hepatic DCs through …
directed at controlling hepatic … the release of inflammatory cytokines by hepatic DCs through …
[PDF][PDF] “Digestive Inflammation and New Therapeutical Targets”
A Couvineau, C Haumaitre - International Journal of Molecular Sciences, 2024 - mdpi.com
69 天前 - … diseases (IBDs) and other immune-mediated diseases. IFX is a monoclonal antibody
directed against TNFα, a major inflammatory cytokine … and New Therapeutic Targets” want …
directed against TNFα, a major inflammatory cytokine … and New Therapeutic Targets” want …
Genomic Landscape of Murine Metabolic-dysfunction Associated Steatohepatitis (MASH): Unveiling Key Molecular Signatures through Meta-Analysis and Fisher's …
V Andrade, Y Shu - 2024 - archive.hshsl.umaryland.edu
72 天前 - … the understanding of the disease and finding potential therapeutic targets. … to
liver damage. - Pathways consistent with clinical manifestations of the disease include cytokine …
liver damage. - Pathways consistent with clinical manifestations of the disease include cytokine …
… of inflammatory bowel disease complicated with metabolic fatty liver and two-sample Mendelian randomization study of the causal relationships behind the disease
Z Wei, J Wang - Frontiers in Immunology, 2024 - frontiersin.org
79 天前 - … IBD and NAFLD and identify potential therapeutic targets. … involve the liver (1), with
nonalcoholic fatty liver disease (… of viral egg white with cytokines and cytokine receptors, thus …
nonalcoholic fatty liver disease (… of viral egg white with cytokines and cytokine receptors, thus …
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
K Takeuchi, K Yamaguchi, Y Takahashi, K Yano… - 2024 - researchsquare.com
79 天前 - … GDF15 and FGF21, stress-responsive cytokines primarily secreted from liver, are
promising therapeutic targets for metabolic dysfunction-associated steatotic liver disease (…
promising therapeutic targets for metabolic dysfunction-associated steatotic liver disease (…
CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B
J Song, L Liu, Z Wang, D Xie, NLB Azami, L Lu… - Heliyon, 2024 - cell.com
90 天前 - … Cytokines are closely associated with both immune … liver diseases patients died
from cirrhosis or liver cancer [ … therapeutic targets and discover new anti-fibrosis drugs (Fig. 1). …
from cirrhosis or liver cancer [ … therapeutic targets and discover new anti-fibrosis drugs (Fig. 1). …
Intestine-specific homeobox edits macrophage polarization in the disease microenvironment by activating inflammasome activity
LT Wang, SH Hsu - Cancer Research, 2024 - AACR
93 天前 - … -produced cytokines from tumor cells on disease progression … -TWIST1 complex
in liver disease and tumor progression on … preventive and therapeutic targets in liver disease. …
in liver disease and tumor progression on … preventive and therapeutic targets in liver disease. …